CommercialCoverageMedium impact
08.00.51l, Enzyme Replacement for the Treatment of Gaucher's Disease
Independence Blue Cross·Endocrinology, Hematology, Oncology +1 more·Medical Policy
Effective date
May 28, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross has reissued their enzyme replacement therapy policy for Gaucher's Disease treatment, effective May 28, 2025. This is a policy reissue rather than new content, but billing teams should review for any potential changes to coverage criteria or requirements.
Action Required
By May 28, 2025: Billing team should review the full reissued policy at the provided URL to identify any changes to coverage criteria, prior authorization requirements, or billing guidelines for Gaucher's Disease enzyme replacement therapy. Update internal procedures if any modifications are found.